课题基金 / 基金详情

CAMERA: Combination antibiotic treatment for Methicillin Resistant Staphylococcus Aureus Bacteraemia - a Randomised Controlled Trial

CAMERA: Combination antibiotic treatment for Methicillin Resistant Staphylococcus Aureus Bacteraemia - a Randomised Controlled Trial
CAMERA:抗生素联合治疗耐甲氧西林金黄色葡萄球菌菌血症 - 一项随机对照试验
批准号:
nhmrc : GNT1078930
负责人:
A/Pr Joshua Davis
金额:
$111.35万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 --

项目摘要

项目成果

A/Pr Joshua Davis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
MRSA (golden staph) is resistant to the most useful class of antibiotics: beta-lactams. It is more difficult to treat than antibiotic-sensitive strains. Standard treatment for MRSA is vancomycin but it has high failure rates. Although MRSA is resistant to beta-lactams, lab studies show that they enhance vancomycin’s bacterial killing when used together. CAMERA2 is an RCT comparing vancomycin alone to combination therapy (vancomycin plus flucloxacillin) for adults with MRSA blood stream infection
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strengthening the evidence base for the management of common severe infectious diseases
  • 批准号:
    nhmrc : GNT1160331
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $29.0万
  • 财政年份:
    2019
  • 负责人:
    A/Pr Joshua Davis
  • 依托单位:
Bacterial and Host Drivers of Fulminant Community-acquired Acinetobacter baumannii Infection
  • 批准号:
    nhmrc : 1144294
  • 项目类别:
    Project Grants
  • 资助金额:
    $49.31万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Joshua Davis
  • 依托单位:
Bacterial and Host Drivers of Fulminant Community-acquired Acinetobacter baumannii Infection
  • 批准号:
    nhmrc : GNT1144294
  • 项目类别:
    Project Grants
  • 资助金额:
    $72.93万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Joshua Davis
  • 依托单位:
Addressing important evidence gaps in the management of severe infectious diseases
  • 批准号:
    nhmrc : 1083105
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $17.13万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Joshua Davis
  • 依托单位:
海外基金